Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Sustiva granted traditional FDA approval based on duration of treatment response

Feb. 15, 2000

Abacavir/mycophenolic acid combination active against multidrug-resistant HIV-1

Feb. 15, 2000

PPD Discovery and Agouron establish alliance seeking new anti-HIV targets

Feb. 11, 2000

Mechanism of anti-HIV activity of polyanionic dendrimers explored

Feb. 10, 2000

Triangle presents first clinical data for DAPD at major scientific forum

Feb. 9, 2000

Lack of resistance to investigational NNRTI during early clinical trials

Feb. 9, 2000

MMP-9: a new target for anti-HIV drugs?

Feb. 9, 2000

Research on new anti-HIV agents continues at DuPont

Feb. 9, 2000

Progenics reviews progress in development of new AIDS therapies at major conference

Feb. 9, 2000

United Biomedical reports progress toward the development of a potential AIDS vaccine

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026